Journal of Biomedical and Translational Research

Research Institute of Veterinary Medicine Chungbuk National University (충북대학교 동물의학연구소)
권호 표지
DOI QR코드

DOI QR Code

The effect of Puerariae Radix on ovariectomy-induced bone loss in C3H/HeN mice

  • Ahn, Byungsu (College of Veterinary Medicine, Chonnam National University) ;
  • Lee, Sueun (College of Veterinary Medicine, Chonnam National University) ;
  • Kang, Sohi (College of Veterinary Medicine, Chonnam National University) ;
  • Moon, Changjong (College of Veterinary Medicine, Chonnam National University) ;
  • Kim, Jong-Choon (College of Veterinary Medicine, Chonnam National University) ;
  • Jang, Jong-Sik (College of Ecology and Environmental Science, Kyungpook National University) ;
  • Kim, Sung-Ho (College of Veterinary Medicine, Chonnam National University)
  • Received : 2018.08.17
  • Accepted : 2018.11.08
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Osteoporosis is a major worldwide public health problem that poses a great economic burden to society. Puerariae Radix, the dried root of Pueraria lobata (Wild.) Ohwi, has been widely used in Asia. This study investigated the effects of Puerariae Radix (PR) on bone loss in ovariectomized (OVX) mice. C3H/HeN mice (10 weeks old) were divided into sham and OVX groups. The OVX mice were treated with vehicle, $17{\beta}-estradiol$ ($E_2$), PR (oral administration, 250 mg/kg/day) or PR (intraperitoneal administration, 50 mg/kg/every other day) for 6 weeks. Grip strength, uterus weight, serum alkaline phosphatase (ALP), estradiol concentration and osteoclast surface levels were measured. Tibiae were analyzed using microcomputed tomography. There were no significant differences in the degree of grip strength, body weight and uterine weight between OVX group and PR-treated group. As compared with the OVX group, the serum estradiol levels were significantly increased in the PR-treated group. PR (i.p.) significantly preserved trabecular bone volume, trabecular bone number, structure model index and bone mineral density of proximal tibiae metaphysic. The administration of PR lowered serum ALP and osteoclast surface levels in OVX mice, suggesting that PR can reduce the bone turnover rate in mice. The results indicate that the supply of PR can prevent OVX-induced bone loss in mice.

Keywords

References

  1. Cauley JA. Osteoporosis: fracture epidemiology update 2016. Curr Opin Rheumatol 2017;29:150-156. https://doi.org/10.1097/BOR.0000000000000365
  2. Cashman KD. Diet, nutrition, and bone health. J Nutr 2007;137:2507S-2512S. https://doi.org/10.1093/jn/137.11.2507S
  3. Gallagher JC. Role of estrogens in the management of postmenopausal bone loss. Rheum Dis Clin North Am 2001;27:143-162. https://doi.org/10.1016/S0889-857X(05)70191-5
  4. Khan M, Cheung AM, Khan AA. Drug-related adverse events of osteoporosis therapy. Endocrinol Metab Clin North Am. 2017;46:181-192. https://doi.org/10.1016/j.ecl.2016.09.009
  5. Sirotkin AV, Harrath AH. Phytoestrogens and their effects. Eur J Pharmacol. 2014;741:230-236. https://doi.org/10.1016/j.ejphar.2014.07.057
  6. Cotter A, Cashman KD. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 2003;61:346-351. https://doi.org/10.1301/nr.2003.oct.346-351
  7. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002;17:1904-1912. https://doi.org/10.1359/jbmr.2002.17.10.1904
  8. Cassidy A, Albertazzi P, Lise NI, Hall W, Williamson G, Tetens I, Atkins S, Cross H, Manios Y. Critical review of health effects of soyabean phyto-oestrogens in postmenopausal women. Proc Nutr Soc 2006;65:76-92. https://doi.org/10.1079/PNS2005476
  9. Chen H, Zhou X, Emura S, Shoumura S. Site-specific bone loss in senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis. Exp Gerontol 2009;44:792-798. https://doi.org/10.1016/j.exger.2009.09.009
  10. Aydin G, Atalar E, Keles I, Tosun A, Zog G, Keles H, Orkun S. Predictive value of grip strength for bone mineral density in males: site specific or systemic? Rheumatol Int 2006;27:125-129. https://doi.org/10.1007/s00296-006-0178-4
  11. Kim IG, Kang SC, Kim KC, Choung ES, Zee OP. Screening of estrogenic and antiestrogenic activities from medicinal plants. Environ Toxicol Pharmacol 2008;25:75-82. https://doi.org/10.1016/j.etap.2007.09.002
  12. Meyer OA, Tilson HA, Byrd WC, Riley MT. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1979;1:233-236.
  13. Gao J, Tiwari-Pandey R, Samadfam R, Yang Y, Miao D, Karaplis AC, Sairam MR, Goltzman D. Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone. Endocrinology 2007;148:2613-2621. https://doi.org/10.1210/en.2006-1404
  14. Yang M, Jang H, Lee HJ, Moon C, Kim JC, Jang JS, Jung U, Jo SK, Kim SH. Evaluation of effect of red ginseng on ovariectomy-induced bone loss in C3H/HeN mice. J Biomed Res 2014;15:12-18. https://doi.org/10.12729/jbr.2014.15.1.012
  15. Kanno J, Kato H, Iwata T, Inoue T. Phytoestrogen-low diet for endocrine disruptor studies. J Agric Food Chem 2002;50:3883-3885. https://doi.org/10.1021/jf020235p
  16. Fan LL, O'Keefe DD, Powell WWJr. Pharmacologic studies on radix puerariae: effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. Chin Med J 1985;98:821-832.
  17. Wang X, Wu J, Chiba H, Umegaki K, Yamada K, Ishimi Y. Puerariae radix prevents bone loss in ovariectomized mice. J Bone Miner Metab 2003;21:268-275. https://doi.org/10.1007/s00774-003-0420-z
  18. Hannon RA, Eastell R. Biochemical markers of bone turnover and fracture prediction. J Br Menopause Soc 2003;9:10-15.
  19. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-1538.
  20. Shen Y, Gray DL, Martinez DS. Combined pharmacologic therapy in postmenopausal osteoporosis. Endocrinol Metab Clin North Am 2017;46:193-206. https://doi.org/10.1016/j.ecl.2016.09.008
  21. Yuan SY, Sheng T, Liu LQ, Zhang YL, Liu XM, Ma T, Zheng H, Yan Y, Ishimi Y, Wang XX. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. Chin J Nat Med 2016;14:265-269.
  22. Ok HM, Gebreamanuel MR, Oh SA, Jeon H, Lee WJ, Kwon O. A root-based combination supplement containing Pueraria lobata and Rehmannia glutinosa and exercise preserve bone mass in ovariectomized rats fed a high-fat diet. Calcif Tissue Int 2015;97:624-633. https://doi.org/10.1007/s00223-015-0057-7
  23. Lv H, Che T, Tang X, Liu L, Cheng J. Puerarin enhances proliferation and osteoblastic differentiation of human bone marrow stromal cells via a nitric oxide/cyclic guanosine monophosphate signaling pathway. Mol Med Rep 2015;12:2283-2290. https://doi.org/10.3892/mmr.2015.3647
  24. Li H, Chen B, Pang G, Chen J, Xie J, Huang H. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism. Pharm Biol 2016;54:111-117. https://doi.org/10.3109/13880209.2015.1017885
  25. Cassidy A. Dietary phytoestrogens and bone health. J Br Menopause Soc 2003;9:17-21.